Tumor necrosis factor inhibitors
US8318699B2 · kind B2 · utility
0Cited by
2References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 31, 2006 |
| Grant date | Nov 27, 2012 |
| Priority date | — |
| Expiry date | Sep 4, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/82
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.